Inventor · disambiguated record
William Marshall
Also filed as: MARSHALL WILLIAM · MARSHALL WILLIAM S · MARSHALL WILLIAM SHAW
136 granted patents·92 pending applications·8,287 citations·filing 1991–2021
99Inventor score
Files withDHARMACON INC150KHVOROVA ANASTASIA38THERMO FISHER SCIENTIFIC INC22AMGEN INC2DALBY CHRISTINA2
Top patents by PatentIndex Score
228 records- 0199US8090542B2Functional and hyperfunctional siRNAKHVOROVA ANASTASIA·Filed 2003·Granted Jan 3, 2012·245 cites·36 claims
- 0299US7833989B2siRNA targeting connective tissue growth factor (CTGF)DHARMACON INC·Filed 2009·Granted Nov 16, 2010·44 cites·20 claims
- 0399US7834170B2Functional and hyperfunctional siRNADHARMACON INC·Filed 2005·Granted Nov 16, 2010·79 cites·34 claims
- 0499US7820809B2Functional and hyperfunctional siRNA directed against Bcl-2DHARMACON INC·Filed 2005·Granted Oct 26, 2010·79 cites·9 claims
- 0599US7745611B2siRNA targeting KRASDHARMACON INC·Filed 2009·Granted Jun 29, 2010·43 cites·20 claims
- 0699US7745612B2siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4)DHARMACON INC·Filed 2009·Granted Jun 29, 2010·46 cites·20 claims
- 0799US7741470B2siRNA targeting gremlinDHARMACON INC·Filed 2009·Granted Jun 22, 2010·42 cites·20 claims
- 0899US7737267B2siRNA targeting hypoxia-inducible factor 1DHARMACON INC·Filed 2009·Granted Jun 15, 2010·43 cites·20 claims
- 0999US7696344B2siRNA targeting complement factor BDHARMACON INC·Filed 2006·Granted Apr 13, 2010·84 cites·16 claims
- 1099US7691997B2Functional and hyperfunctional siRNADHARMACON INC·Filed 2005·Granted Apr 6, 2010·314 cites·20 claims
- 1199US7678896B2siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase)DHARMACON INC·Filed 2007·Granted Mar 16, 2010·60 cites·15 claims
- 1299US7674896B2siRNA targeting BCL2L1DHARMACON INC·Filed 2006·Granted Mar 9, 2010·59 cites·20 claims
- 1399US7666853B2siRNA targeting connective tissue growth factor (CTGF)DHARMACON INC·Filed 2009·Granted Feb 23, 2010·68 cites·20 claims
- 1499US7662950B2siRNA targeting myeloid differentiation primary response gene (88) (MYD88)DHARMACON INC·Filed 2007·Granted Feb 16, 2010·59 cites·20 claims
- 1599US7655789B2siRNA targeting transient receptor potential cation channel, subfamily V, member 1 (TRPV1)DHARMACON INC·Filed 2007·Granted Feb 2, 2010·68 cites·20 claims
- 1699US7655788B2siRNA targeting DNA-damage-inducible transcript 4 (DDIT4)DHARMACON INC·Filed 2007·Granted Feb 2, 2010·110 cites·20 claims
- 1799US7645870B2siRNA targeting proteasome 26S subunit, non-ATPase, 10 (Gankyrin or PSMD10)DHARMACON INC·Filed 2007·Granted Jan 12, 2010·71 cites·20 claims
- 1899US7645869B2siRNA targeting spleen tyrosine kinaseDHARMACON INC·Filed 2006·Granted Jan 12, 2010·64 cites·20 claims
- 1999US7642349B2siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)DHARMACON INC·Filed 2008·Granted Jan 5, 2010·69 cites·20 claims
- 2099US7638622B2SiRNA targeting intercellular adhesion molecule 1 (ICAM1)DHARMACON INC·Filed 2007·Granted Dec 29, 2009·57 cites·20 claims
- 2199US7638621B2siRNA targeting insulin-like growth factor 1 receptor (IGF-1R)DHARMACON INC·Filed 2007·Granted Dec 29, 2009·60 cites·16 claims
- 2299US7635771B2siRNA targeting amyloid beta (A4) precursor protein (APP)DHARMACON INC·Filed 2007·Granted Dec 22, 2009·68 cites·20 claims
- 2399US7632939B2siRNA targeting proto-oncogene METDHARMACON INC·Filed 2007·Granted Dec 15, 2009·63 cites·20 claims
- 2499US7632938B2siRNA targeting superoxide dismutase 1 (SOD1)DHARMACON INC·Filed 2007·Granted Dec 15, 2009·77 cites·20 claims
- 2599US7615541B2siRNA targeting TIE-2DHARMACON INC·Filed 2006·Granted Nov 10, 2009·68 cites·20 claims
- 2699US7608706B2siRNA targeting ras-related nuclear proteinDHARMACON INC·Filed 2006·Granted Oct 27, 2009·69 cites·20 claims
- 2799US7608707B2siRNA targeting survivinDHARMACON INC·Filed 2006·Granted Oct 27, 2009·77 cites·20 claims
- 2899US7605252B2siRNA targeting kinase insert domain receptor (KDR)DHARMACON INC·Filed 2007·Granted Oct 20, 2009·65 cites·20 claims
- 2999US7598370B2siRNA targeting polo-like kinase-1 (PLK-1)DHARMACON INC·Filed 2007·Granted Oct 6, 2009·86 cites·20 claims
- 3099US7598369B2siRNA targeting histamine receptor H1DHARMACON INC·Filed 2006·Granted Oct 6, 2009·76 cites·20 claims
- 3199US7595388B2siRNA targeting EPH receptor A3 (EPHA3)DHARMACON INC·Filed 2007·Granted Sep 29, 2009·73 cites·20 claims
- 3299US7595389B2siRNA targeting casitas B cell lymphoma-B (CBL-B)DHARMACON INC·Filed 2007·Granted Sep 29, 2009·71 cites·20 claims
- 3399US7595387B2Modified polynucleotides for reducing off-target effects in RNA interferenceDHARMACON INC·Filed 2004·Granted Sep 29, 2009·173 cites·10 claims
- 3499US7592443B2siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4)DHARMACON INC·Filed 2007·Granted Sep 22, 2009·84 cites·20 claims
- 3599US7592444B2siRNA targeting myeloid cell leukemia sequence 1DHARMACON INC·Filed 2009·Granted Sep 22, 2009·72 cites·20 claims
- 3699US7589191B2siRNA targeting hypoxia-inducible factor 1DHARMACON INC·Filed 2009·Granted Sep 15, 2009·75 cites·19 claims
- 3799US7582746B2siRNA targeting complement component 3 (C3)DHARMACON INC·Filed 2007·Granted Sep 1, 2009·81 cites·20 claims
- 3899US7579457B2siRNA targeting carbonic anhydrase IIDHARMACON INC·Filed 2006·Granted Aug 25, 2009·109 cites·22 claims
- 3999US7579458B2siRNA targeting synuclein, alpha (SNCA-1)DHARMACON INC·Filed 2007·Granted Aug 25, 2009·83 cites·19 claims
- 4099US7576196B2siRNA targeting transducin (beta)-like 3 (TBL3)DHARMACON INC·Filed 2008·Granted Aug 18, 2009·86 cites·20 claims
- 4199US7576197B2SiRNA targeting KRASDHARMACON INC·Filed 2008·Granted Aug 18, 2009·86 cites·18 claims
- 4299US7569684B2siRNA targeting gremlinDHARMACON INC·Filed 2007·Granted Aug 4, 2009·81 cites·17 claims
- 4399US7550572B2siRNA targeting cell division cycle 20 homolog (CDC20)DHARMACON INC·Filed 2007·Granted Jun 23, 2009·84 cites·20 claims
- 4499US7541453B2siRNA targeting aquaporin 4DHARMACON INC·Filed 2006·Granted Jun 2, 2009·88 cites·20 claims
- 4599US7521191B2siRNA targeting connexin 43DHARMACON INC·Filed 2007·Granted Apr 21, 2009·127 cites·20 claims
- 4699US7514550B2siRNA targeting myeloid cell leukemia sequence 1DHARMACON INC·Filed 2007·Granted Apr 7, 2009·108 cites·18 claims
- 4799US7511132B2Functional and hyperfunctional siRNA directed against Bcl-2DHARMACON INC·Filed 2007·Granted Mar 31, 2009·118 cites·10 claims
- 4899US7507811B2siRNA targeting KRASDHARMACON INC·Filed 2006·Granted Mar 24, 2009·136 cites·13 claims
- 4999US5278302APolynucleotide phosphorodithioatesUNIVERSITY PATENTS INC·Filed 1991·Granted Jan 11, 1994·1.4k cites·17 claims
- 5098US7834171B2Modified polynucleotides for reducing off-target effects in RNA interferenceDHARMACON INC·Filed 2007·Granted Nov 16, 2010·68 cites·9 claims
Showing the top 50 of 228 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when William Marshall files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →